Amelie Pielen

Cardiovascular Risk Factors in Central Retinal Artery Occlusion

Josep Callizo, Nicolas Feltgen, Stefanie Pantenburg et al. · Ophthalmology · 2015 · 166 citations

Diabetic Retinopathy, Retina, Cardiovascular Disease +8

Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD

Christoph Ehlken, Sven Jungmann, Daniel Böhringer et al. · Eye · 2014 · 92 citations · Full text

Regenerative Medicine, Translational Medicine, Novel Therapy +12

Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study

Hans Hoerauf, Nicolas Feltgen, Eva‐Maria Paulus et al. · American Journal of Ophthalmology · 2016 · 85 citations

Diabetic Retinopathy, Ocular Disease, Vitreous Body +8

Head‐to‐head comparison of ranibizumab PRN versus single‐dose dexamethasone for branch retinal vein occlusion (COMRADE‐B)

Lars‐Olof Hattenbach, Nicolas Feltgen, Thomas Bertelmann et al. · Acta Ophthalmologica · 2017 · 64 citations · Full text

Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells.

Julia Biermann, Jennifer Boyle, Amelie Pielen et al. · PubMed · 2011 · 59 citations · Full text